Wednesday, May 18

Veterinary Dermatology Drugs Market Value – US$13.0 Bn By 2028 Stats Prediction by Acumen Research and Consulting

Acumen Research and Consulting recently published report titled Veterinary Dermatology Drugs Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2021 – 2028”, The market accounted US$7.8 Bn in 2020 with a significant CAGR of 9.6% during the forecast period of 2021 to 2028.

Download Free Sample Pages –

Market Segmentation

The global veterinary dermatology drugs market is divided into four categories: animal type, route of administration, indication, and distribution channel. The market is divided into two categories such as companion animals and livestock animals. The market is divided into three sections based on administration methods such as oral, topical, and injectable. According to indication, the market is divided into parasitic infection, allergic infection, and others. In addition, distribution channels are classified as retail, e-commerce, and hospital pharmacies.

Companion animals account for a significant portion of the market in terms of animal type, contributing to overall market growth. Furthermore, in terms of route of administration, the oral route of administration accounts for the lion’s share of the market; while parasitic infection shows promising growth for the overall market by indication type. Based on distribution channel, hospital pharmacies account for a significant portion of the overall growth of the veterinary dermatology drugs market from 2021 to 2028.

View Complete Table Of Content –

COVID-19 impact on global veterinary dermatology drugs market

According to the Federation of Veterinarians of Europe (FVE) report, many small and medium-sized businesses involved in veterinary practices are experiencing financial difficulties. Revenue is down nearly 50% in the majority of countries. Furthermore, due to self-isolation or social distancing measures, the veterinary workforce is overstressed in some countries. Furthermore, strong government support during the COVID-19 pandemic favors the veterinary dermatology drugs market. According to the American Veterinary Medical Association (AVMA), health officials in the United States and around the world are working hard to combat the COVID-19 pandemic. Furthermore, the AVMA is committed to providing accurate, up-to-date information and resources to assist the veterinary community in providing services during the onset of a pandemic.

Regional Landscape

North America dominates the veterinary dermatology market; Asia Pacific to register fastest growing CAGR for the analysis period during 2020 to 2028

The most influential factor for the growth of the regional market is the growing awareness of pet insurance. According to the North American Pet Health Insurance Association (NAPHIA), the North American pet health insurance sector will exceed US$2.1 Bn in 2020. Furthermore, premium volumes in the United States accounted for US$1.9 Bn in 2020, representing a 27.5% increase over 2019. In Canada, total premium volume totaled US$188.3 Mn, a 17.2% increase over the previous year. This is the contributing factor for the regional growth ultimately contributing for the overall veterinary dermatology drugs market. Furthermore, because of the pandemic, stay-at-home and work-from-home measures introduced during the pandemic created close bonds between pet owners and their pets, which drives regional growth overall.

Asia Pacific, on the other hand, has the fastest growing CAGR for the veterinary dermatology drugs market from 2021 to 2028. The companion animal/pet care industry contributes to the Indian Animal Health Industry’s fourth important pillar. This is fairly well-established industry allows for much greater levels of accessibility, with pets being widely adopted in India’s cities and urban areas. This proves to be a critical factor in the overall market’s growth.

To receive personalized service, please share your research needs here@

Competitive Landscape

The prominent players of the global veterinary dermatology drugs market include Elanco Animal Health, Vetoquinol SA, Ceva, Intervet Inc. (a subsidiary of Merck & Co. Inc.), Zoetis, Virbac, Bimeda, Inc., Vivaldis, and among others

The market for veterinary dermatology drugs market is highly competitive and fragmented due to the presence of large number of multinational as well as local players. The leading players are constantly looking to increase their share in the market.

  • In May 2021, Elanco Animal Health, announced launching of new product namely, “ZoaShield” in the US that offers poultry producers a proven and flexible solution keeping coccidiosis under control in an easy, manageable way. Additionally, the company equips producers with a wide range of tools they can use to prevent, treat, and control common poultry challenges in order to keep operations running smoothly.
  • In December 2019, Vetoquinol SA, announced partnership with Klox Technologies Limited. Through this partnership Vetoquinol will manufacture and commercialize Klox’s fluorescent light energy (FLE) products among animal health. Furthermore, this partnership will complement its strong presence and enable to significantly improve the lives of pets and their owners living with difficult to treat conditions.


Would like to place an order or any question, please feel free to contact at | +1 407 915 4157

About Acumen:

Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

For Latest Update Follow Us:

Content Source: